Clin2
NCT07636356Possibly a fitNot yet recruiting

THCV treatment for smokers

Tobacco Use DisorderSmoking Cessation

Part of Mental health clinical trials.

This study tests whether a cannabis component called THCV helps people who smoke cigarettes reduce their smoking or quit. It might help because THCV may affect how your body responds to nicotine and cravings.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
32 people
Ages
21 years to 65 years
Study type
Interventional

Who can take part

  • Be between 21 and 65 years old.
  • Smoke 10 or more cigarettes per day.
  • Have not quit smoking for more than 3 months in the past year.
  • Have used cannabis products at least 10 times in your life and within the last 3 months.
  • Agree to stop using all other cannabis products, medications, and supplements during the study.
  • If you are female, agree to use one of the approved birth control methods or abstain from sex.
  • Have no current substance use disorder (other than nicotine), no serious mental health conditions, and be generally healthy (including normal kidney and liver function).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05445804Recruiting· Phase 1
Oral cannabidiol (CBD) to help you quit tobacco

This Phase 1 study tests whether taking oral CBD can help people quit tobacco. It also checks safety and helps researchers learn how people respond to the treatment while they practice quitting.

Baltimore, Maryland
NCT06883162Recruiting· Phase 3
A study to help people stop smoking tobacco and reduce cannabis use

This study tests whether a medication called varenicline (or a placebo) can help people who use both tobacco and cannabis to quit or cut back. It takes place in South Carolina and lasts 12 weeks.

Charleston, South Carolina
NCT06688539Recruiting· Phase 4
Quitting e-cigarettes in adults who also use cannabis

This trial tests if varenicline, a stop-smoking medication, can help people ages 18 to 40 quit e-cigarettes while also using cannabis. It's designed for regular e-cigarette users who want to quit and who use cannabis at least 10 days per month.

Charleston, South Carolina
NCT06239350Recruiting
Young adult tobacco and cannabis co-use study

This study tests a program to help young adults who use both nicotine and cannabis products reduce or quit nicotine use. If you are between 18 and 25, use nicotine products at least 20 days a month and cannabis at least 10 days a month, and want to quit nicotine, you may be eligible.

Charleston, South Carolina
NCT06218056Recruiting· Phase 2
CBD for reducing cigarette smoking in a treatment center

This study tests whether a daily dose of cannabidiol (CBD) can help people who smoke at least 5 cigarettes a day cut down or quit. It is for people staying at a treatment center in Los Angeles where cannabis use is not allowed.

North Hollywood, California
NCT07145866Recruiting· Phase 4
Varenicline and TMS for quitting nicotine use

This study tests whether combining the medication varenicline (Chantix) with a special brain stimulation treatment (TMS) can help people quit vaping or smoking nicotine. If you're motivated to quit and use nicotine daily, you may be able to join.

Boston, Massachusetts

Hear when a new Tobacco Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.